Hexarelin 4mg Vial 90 Day Protocol

Peptide for research purposes

$360.00

Peptide Class or Classification
Synthetic hexapeptide; growth hormone secretagogue (GHS); ghrelin receptor agonist.

Top 5 Benefits and Uses

  • Stimulates pulsatile release of growth hormone and IGF-1

  • Enhances muscle strength and lean body mass in anabolic models

  • Exhibits cardioprotective effects post-myocardial infarction and in heart failure

  • Promotes joint and connective tissue healing

  • Modulates cortisol and prolactin levels in endocrine research

Hexarelin (His-D-2-methyl-Trp-Ala-Trp-D-Phe-Lys-NH₂) is a synthetic hexapeptide developed in the 1990s as a growth hormone secretagogue. It belongs to the class of GH-releasing peptides (GHRPs) and was originally studied as a more potent analog of GHRP-6. Hexarelin binds to the ghrelin receptor (GHS-R1a) and stimulates the release of endogenous growth hormone (GH). It has been extensively investigated in both preclinical and clinical models for its anabolic, cardioprotective, and regenerative properties.

Experience premium quality with DNAxis Hexarelin 4mg vial, expertly formulated for advanced scientific and laboratory research purposes. Each sterile, clear-glass vial contains 4mg of high-purity Hexarelin peptide, ensuring reliable performance and consistent results. Ideal for research professionals seeking accuracy and excellence in peptide studies. Supplied in a compact, easy-to-handle vial for optimal convenience and maximum integrity.

All peptide sales are final. Due to the sensitive nature of research peptides, we cannot accept returns or issue refunds once an order has been placed. This policy ensures product integrity, safety, and compliance. Please review your order carefully before completing your purchase.

Disclaimer: All peptide purchases require and include an initial consultation. Peptides are sold for research and educational purposes only. They are not FDA-approved and are not intended to diagnose, treat, cure, or prevent any condition. By purchasing, you agree to these terms.